#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	144	1608	16S	1529	1072	100.0	16S.l15.c30.ctg.1	1472	212.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	727	727	C	232	C	185	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	144	1608	16S	1529	1072	100.0	16S.l15.c30.ctg.1	1472	212.4	0	HET	.	.	.	C1450T	.	1450	1450	C	993	993	C	241	C,T	162,46	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2786	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3901	213.4	0	.	n	.	0	T695C	SNP	695	695	T	1204	1204	C	211	C,T	174,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2786	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3901	213.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2480	2480	C	253	C	214	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2786	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3901	213.4	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3106	3106	T	257	T	211	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2786	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3901	213.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2554	2554	A	274	A	235	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	244	folP	855	855	100.0	folP.l15.c4.ctg.1	1844	39.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1168	1170	AGC	66;67;67	A;G;C,T	51;53;51,1	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	638	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3929	48.7	1	SNP	p	S91F	1	.	.	271	273	TTC	866	868	TTC	57;57;58	T;T,C;C	49;46,1;48	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	638	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3929	48.7	1	SNP	p	D95G	1	.	.	283	285	GGC	878	880	GGC	57;57;57	G;G,A,T;C,A	48;47,1,1;46,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	638	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3929	48.7	1	SNP	p	G95N	0	.	.	283	285	GGC	878	880	GGC	57;57;57	G;G,A,T;C,A	48;47,1,1;46,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	322	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1851	52.2	1	SNP	p	G45D	0	.	.	133	135	GGC	790	792	GGC	86;85;84	G;G,A;C	70;67,1;69	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	166	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1445	34.4	0	.	n	.	0	A197.	DEL	197	197	A	876	876	A	74	A	64	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	618	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3363	54.9	1	SNP	p	D86N	0	.	.	256	258	GAC	862	864	GAC	76;74;75	G;A;C	58;55;58	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	618	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3363	54.9	1	SNP	p	R87W	0	.	.	259	261	CGT	865	867	CGT	75;75;75	C;G,T;T	59;58,1;57	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	618	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3363	54.9	1	SNP	p	R87I	0	.	.	259	261	CGT	865	867	CGT	75;75;75	C;G,T;T	59;58,1;57	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	618	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3363	54.9	1	SNP	p	S87R	1	.	.	259	261	CGT	865	867	CGT	75;75;75	C;G,T;T	59;58,1;57	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	618	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3363	54.9	1	SNP	p	S88P	0	.	.	262	264	TCC	868	870	TCC	75;76;76	T;C;C	58;60;61	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	450	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3259	41.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1857	1859	GGC	55;55;55	G;G;C	45;45;44	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	452	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2787	48.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1502	1504	GCC	56;56;56	G;C;C	45;46;46	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	452	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2787	48.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1505	1507	ATG	56;56;56	A;T;G	45;43;46	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	452	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2787	48.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1517	1519	ACC	57;57;57	A;C;C	46;47;47	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	452	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2787	48.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1517	1519	ACC	57;57;57	A;C;C	46;47;47	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	452	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2787	48.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2018	2020	ACC	63;63;63	A;C;C	55;51;56	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	452	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2787	48.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2072	2074	GCG	55;55;55	G;C;G	46;46;46	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	452	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2787	48.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2072	2074	GCG	55;55;55	G;C;G	46;46;46	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	452	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2787	48.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2195	2197	GGT	53;54;55	G;G;T	42;42;45	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	452	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2787	48.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2204	2206	AGC	52;52;52	A,C;G,A;C	43,1;43,1;43	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	452	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2787	48.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2222	2224	CCG	47;47;47	C;C;G	39;42;39	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	614	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3451	53.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1827	1829	CCG	71;71;71	C,T;C;G,T	59,1;57;56,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	306	porA	1146	1146	99.91	porA.l6.c4.ctg.1	2188	41.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	786	786	C	42	C,A	38,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	300	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1741	49.9	0	.	p	.	0	R144Q	NONSYN	430	432	CGG	916	918	CAG	50;50;50	C;A;G	41;43;41	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	300	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1741	49.9	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1114	1116	AGA	61;61;61	A;G;A,T	55;56;51,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	300	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1741	49.9	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1135	1137	GGT	59;59;59	G;G;T	52;54;53	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	300	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1741	49.9	1	SNP	p	G120K	1	.	.	358	360	AAG	844	846	AAG	49;49;49	A;A;G	46;46;47	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	300	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1741	49.9	1	SNP	p	A121N	1	.	.	361	363	AAC	847	849	AAC	49;49;49	A;A;C	45;46;46	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	300	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1741	49.9	1	SNP	p	N121D	0	.	.	361	363	AAC	847	849	AAC	49;49;49	A;A;C	45;46;46	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1056	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5352	59.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	150	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1288	34.7	1	SNP	p	V57M	1	.	.	169	171	ATG	692	694	ATG	46;46;47	A;T;G	38;40;41	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
